This is a routine board appointment with no immediate trading implications. Monitor for any future strategic shifts if Carrel's med-tech expertise influences product or M&A direction.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 27 $50.93entry
- T+1 · 4mo ago +2.04%α +1.80% · $51.97
- T+5 · 4mo ago −1.41%α −2.49% · $50.21
- T+20 · 3mo ago +20.70%α +17.40% · $61.47
- T+60 · 28d ago +37.74%α +34.03% · $70.15
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Inspire Medical Systems appointed Michael H. Carrel, CEO of AtriCure (ATRC), to its Board of Directors effective July 20, 2026. This is a routine board addition with no financial impact or strategic change for the company.
Key Facts
- Michael H. Carrel appointed to Inspire Medical Systems Board of Directors effective July 20, 2026
- Carrel is President, CEO, and director of AtriCure, Inc. (NASDAQ: ATRC)
- Carrel will serve as a Class III director until the 2027 Annual Meeting
- Appointed to Organization and Compensation Committee and Quality, Product Supply and Technology Committee
- Eligible for standard non-employee director compensation: $55,000 annual cash retainer, $7,500 per committee retainer, $300,000 initial RSU award vesting over 3 years, and $200,000 annual RSU award
Financial Impact
No material financial impact. Director compensation is standard and immaterial relative to company size.
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001609550-26-000041 |
| Document: 0001609550-26-000041-index-headers.html | 0001609550-26-000041 |
| Document: 0001609550-26-000041-index.html | 0001609550-26-000041 |
| Document: 0001609550-26-000041.txt | 0001609550-26-000041 |
Track record
16 reports on INSP
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $59.52 Now $59.12 −0.67% settles Nov 17
- Nov 12, 20264d ago SC 13G/A Bearish 4/10 Entry $60.54 to $61.10 Now $59.12 +2.35% ▼ −0.93% −1.29% vs SPY
- Nov 9, 20267d ago Institutional Cluster Mixed 3/10 Entry $62.31 to $62.11 Now $59.12 −5.12% ▼ −0.32% −1.64% vs SPY
- Nov 9, 20267d ago SC 13G/A Bearish 4/10 Entry $62.31 to $62.11 Now $59.12 +5.12% ▲ +0.32% +1.64% vs SPY
- Nov 2, 202614d ago 8-K Mixed 6/10 No price data
- Nov 2, 202614d ago Press Release Neutral 5/10 Entry $61.90 to $66.61 Now $59.12 −4.49% ▲ +7.61% +5.96% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $68.10 to $67.21 Now $59.12 −13.19% ▼ −1.31% −0.83% vs SPY
- Oct 5, 20266w ago Press Release Neutral 1/10 Entry $68.20 Now $59.12 −13.31% No price data
- Jul 27, 202616w ago 3 Neutral 1/10 Entry $51.97 to $51.07 Now $59.12 +13.76% ▼ −1.73% −0.19% vs SPY
- Jul 24, 202616w ago 8-K Neutral 2/10 Viewing Entry $50.93 to $51.97 Now $59.12 +16.08% ▲ +2.04% +1.80% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers